PROPANC BIOPHARMA, INC. Accounts Payable
PROPANC BIOPHARMA, INC. (PPCB) had Accounts Payable of $973.69 thousand as of 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-07-17
- 2026-03-31: Accounts Payable, Current $973.69K.
- 2025-12-31: Accounts Payable, Current $957.48K.
- 2025-09-30: Accounts Payable, Current $1.07M.
- 2025-06-30: Accounts Payable, Current $1.25M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-03-31 | $973.69K S-1 · filed 2026-07-17 |
| 2025-12-31 | $957.48K S-1 · filed 2026-04-10 |
| 2025-09-30 | $1.07M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.25M S-1 · filed 2026-07-17 |
| 2025-03-31 | $1.12M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.22M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $1.24M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.21M S-1 · filed 2026-07-17 |
| 2024-03-31 | $1.19M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.16M 10-Q · filed 2024-02-20 |
| 2023-09-30 | $1.08M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $966.72K 10-K · filed 2024-09-30 |
| 2023-03-31 | $918.20K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $914.49K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $899.23K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $943.02K 10-K · filed 2023-09-28 |
| 2022-03-31 | $967.21K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $920.69K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $826.18K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.00M 10-K · filed 2022-09-28 |
| 2021-03-31 | $950.13K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.02M 10-Q · filed 2021-02-12 |
| 2020-09-30 | $929.83K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $842.16K 10-K · filed 2021-09-28 |
| 2019-09-30 | $959.97K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $917.34K 10-K · filed 2020-10-01 |
| 2019-03-31 | $854.95K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $1.06M 10-Q · filed 2019-02-14 |
| 2018-09-30 | $1.13M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $1.16M 10-K · filed 2019-10-15 |
| 2018-03-31 | $1.21M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.44M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $606.99K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $483.51K 10-K · filed 2018-09-17 |
| 2017-03-31 | $452.14K 10-Q · filed 2017-05-08 |
| 2017-03-02 | $50.00K 10-Q · filed 2017-05-08 |
| 2017-02-13 | $50.00K 10-K · filed 2018-09-17 |
| 2016-12-31 | $441.77K 10-Q · filed 2017-02-14 |
| 2016-09-30 | $326.10K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $370.09K 10-K · filed 2017-09-28 |
| 2016-03-31 | $159.32K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $107.13K 10-Q · filed 2016-02-16 |
| 2015-09-30 | $303.13K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $236.47K 10-K · filed 2016-09-28 |
| 2015-03-31 | $291.03K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $88.09K 10-Q · filed 2015-02-17 |
| 2014-09-30 | $48.84K 10-Q · filed 2014-11-19 |
| 2014-06-30 | $350.00K 10-K · filed 2015-09-30 |
| 2014-03-31 | $332.29K 10-Q · filed 2014-05-20 |
| 2013-12-31 | $311.45K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $259.45K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $272.60K 10-K · filed 2014-10-14 |
| 2013-03-31 | $210.58K 10-Q · filed 2013-05-20 |
| 2012-12-31 | $198.41K 10-Q · filed 2013-02-20 |
| 2012-09-30 | $239.22K 10-Q · filed 2012-11-19 |
| 2012-06-30 | $192.47K 10-K · filed 2013-10-15 |
| 2012-03-31 | $38.34K 10-Q · filed 2012-05-21 |
| 2011-12-31 | $38.95K 10-Q/A · filed 2012-03-07 |
| 2011-06-30 | $27.72K 10-K · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |